Mark Hopman Beta Bionics, Inc. (BBNX) insider trading activity

Shares Held (Direct Ownership) 31.2K

8.55% 3M change

n/a 12M change

Total Value Held N/A

Mark Hopman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 05 2025	SELL Open market or private sale	$234,610 $20.56 p/Share	11,411 Reduced 26.77%	31,215 Common Stock
Sep 05 2025	BUY Exercise of conversion of derivative security	$58,196 $5.1 p/Share	11,411 Added 21.12%	42,626 Common Stock
Sep 04 2025	SELL Open market or private sale	$136,155 $19.97 p/Share	6,818 Reduced 17.93%	31,215 Common Stock
Sep 04 2025	BUY Exercise of conversion of derivative security	$24,219 $5.1 p/Share	4,749 Added 11.1%	38,033 Common Stock
Sep 02 2025	SELL Open market or private sale	$15,993 $18.86 p/Share	848 Reduced 2.48%	33,284 Common Stock
Aug 19 2025	SELL Open market or private sale	$268,384 $16.61 p/Share	16,158 Reduced 32.13%	34,132 Common Stock
Aug 19 2025	BUY Exercise of conversion of derivative security	$82,405 $5.1 p/Share	16,158 Added 24.32%	50,290 Common Stock
Jun 02 2025	SELL Open market or private sale	$15,589 $17.96 p/Share	868 Reduced 2.48%	34,132 Common Stock
Feb 27 2025	BUY Grant, award, or other acquisition	-	35,000 Added 50.0%	35,000 Common Stock

Chief Commercial Officer

Irvine, CA

Receive a notification when an Institution or Guru buys or sells BBNX shares.

Notify only if

Value

Get notified when an Beta Bionics, Inc. insider buys or sells BBNX shares.

Notify only if

Operation

Value

Type

Receive news related to Beta Bionics, Inc.